From Sensors to Smart Devices: How CGM Market is Evolving Rapidly

[thorat Ketan]

The global Continuous Glucose Monitoring (CGM) Market Size, valued at USD 4.62 billion in 2023, is projected to reach a remarkable USD 8.82 billion by 2032, expanding at a Compound Annual Growth Rate (CAGR) of 7.80% during the forecast period 2024–2032, according to the latest market analysis. With the increasing prevalence of diabetes worldwide and rising demand for minimally invasive, real-time monitoring solutions, CGM systems are poised to revolutionize diabetes management.

Continuous Glucose Monitoring systems enable real-time tracking of glucose levels in diabetic patients, offering a significant advancement over traditional blood glucose monitoring techniques. These systems play a critical role in maintaining glycemic control, preventing hypoglycemic events, and reducing the long-term complications of diabetes.

Get Free Sample Report on Continuous Glucose Monitoring Market  

https://www.snsinsider.com/sample-request/3055

Key Market Drivers

1. Rising Global Diabetes Prevalence

The global burden of diabetes continues to rise at an alarming rate. According to the International Diabetes Federation (IDF), over 537 million adults were living with diabetes in 2021, with projections indicating a rise to 783 million by 2045. This surge directly translates to increasing demand for advanced glucose monitoring technologies like CGM, which help patients and clinicians manage the disease more effectively.

2. Advancements in Sensor Technology

Technological innovation is central to the growth of the CGM market. The development of smaller, more accurate, and longer-wear sensors is encouraging both patient compliance and clinical adoption. New generation CGM devices with improved accuracy, longer battery life, and Bluetooth connectivity are reshaping how diabetes is monitored and managed.

3. Increasing Adoption of Telehealth and Remote Patient Monitoring

The COVID-19 pandemic catalyzed the integration of remote healthcare solutions. CGM devices that transmit data in real-time have become invaluable for remote patient monitoring, enabling healthcare providers to make timely interventions. The integration of CGM data with mobile apps, cloud platforms, and wearable devices is creating a seamless patient-doctor interaction loop.

4. Patient-Centric Solutions Driving Consumer Demand

Patients are increasingly demanding tools that provide convenience, better control, and real-time feedback. CGM systems address these needs by reducing the need for frequent finger-prick tests and providing comprehensive glucose data trends. Enhanced user experience through painless insertion, smartphone compatibility, and alert systems further supports the market growth.

Key Segments

By Component

• Transmitters
• Sensors
• Receivers

By Connectivity

• Bluetooth
• 4G

By End Use

• Hospitals
• Homecare Settings
• Others

KEY PLAYERS:

The players operating in the continuous glucose monitoring market are the following:

• Abbott Laboratories: Freestyle Libre 1, Freestyle Libre 3, Freestyle Libre 3 Pro
• Dexcom: Dexcom G6, Dexcom G7
• Medtronic: Enlite sensor, MiniMed 670G system
• Tandem Diabetes Care: t: slim X2 pump
• Senseonics Holdings: Eversense XL
• Nipro Corporation: Nipro Cosmos system
• Roche Diagnostics: Accu-Chek Aviva Plus CGM system
• Hoffmann-La Roche Ltd: (Parent company of Roche Diagnostics)
• Ypsomed: YpsoPump, YpsoDiab system
• Insulet Corporation: Omnipod system
• Medtrum Technologies: MiaoMiao 2, MiaoMiao 3
• FreeStyle Libre: Freestyle Libre 2, Freestyle Libre 3
• LifeScan: OneTouch Reveal system

Strategic Developments:

• 2024: Dexcom launched the Dexcom G7 system with an ultra-slim wearable sensor and faster warm-up time.
• 2023: Abbott received FDA approval for the FreeStyle Libre 3 system, the smallest and most accurate CGM sensor to date.
• 2023: Medtronic announced its new SmartGuard technology, which automates insulin delivery based on CGM readings for advanced diabetes management.

Market Opportunities

1. Integration with Insulin Delivery Devices

The convergence of CGM systems with insulin pumps and closed-loop systems (artificial pancreas) opens new avenues for comprehensive diabetes care. These integrated systems offer autonomous insulin dosing, reducing the burden on patients and improving quality of life.

2. Non-Invasive CGM Devices

Startups and R&D efforts are actively exploring non-invasive CGM options that eliminate the need for subcutaneous sensor insertion. Such innovation could revolutionize the industry and expand its user base dramatically.

3. Wearables and Smart Device Ecosystems

The integration of CGM data into wearable platforms such as smartwatches is a promising development. It supports continuous health monitoring and improves patient adherence through user-friendly interfaces and real-time alerts.

4. Expanding Use in Pediatric and Geriatric Care

With growing concern around childhood obesity and rising elderly populations, CGM devices are being increasingly tailored to these groups. Pediatric-friendly CGM solutions with parental monitoring capabilities and simplified geriatric versions are in high demand.

Challenges and Restraints

While the CGM market outlook is positive, there are challenges that could restrain growth:

• High Device Costs: Despite the benefits, CGM systems remain expensive, especially in low- and middle-income regions, limiting adoption.
• Data Privacy Concerns: As devices become more connected, cybersecurity and data protection become critical.
• User Training and Technical Knowledge: Adequate education is required for both patients and healthcare providers to ensure proper usage and interpretation of data.

Future Outlook

The future of the Continuous Glucose Monitoring Market is shaped by innovation, integration, and increased accessibility. As technological barriers reduce and healthcare policies evolve to support digital monitoring tools, CGM systems are expected to become a cornerstone of chronic disease management.

Between 2023 and 2032, the market is projected to nearly double in size, with USD 8.82 billion in forecasted revenues by the end of the period. Strategic partnerships, cost optimization, and product customization will be key to unlocking the next phase of growth in this dynamic market.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: [phone] (US) | [phone] (UK)